Metformin Bluefish (Metformin Hydrochloride)

Metformin reduces hepatic glucose production, decreases intestinal absorption of glucose, and enhances peripheral insulin sensitivity, allowing cells to take up glucose more efficiently without increasing insulin secretion.

The appropriate dose of Metformin Bluefish is determined by the prescribing clinician based on the individual’s medical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of metformin during pregnancy or lactation is not fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy because it improves insulin sensitivity without causing weight gain. Compared with sulfonylureas, it has a lower risk of hypoglycaemia, and unlike insulin, it is taken orally.

Store Metformin Bluefish at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and discard any product that appears discoloured or damaged.

Metformin Bluefish is taken orally, usually with meals to minimise gastrointestinal upset. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute medical illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain or unusual fatigue develop.

Metformin Bluefish should be avoided in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast studies without adequate hydration.